This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Tim Luker, Ph.D.
VP, Emerging Technology & Innovation at Eli Lilly & Company


Tim Luker is currently VP Emerging Technology and Innovation at Eli Lilly. He leads Lilly's external innovation process in Europe within Global Corporate Business Development, primarily targeting transformational early stage research across 5 therapy areas. This role also supports Lilly’s multiple external VC fund investments and runs due diligence and search and evaluation initiatives.

Tim is an experienced drug hunter with >20 years’ experience (>60 patents and publications). Prior to Lilly he worked at Shire, Polleo Pharma (founder, company acquired) and AstraZeneca.

Tim has a PhD in chemistry from the University of Southampton, carried out post-doctoral research at Universiteit Van Amsterdam and is a Prince2 qualified project manager.

Agenda Sessions

  • Panel Discussion: Partnering to Commercialise Therapeutic Platform Technologies for Drug Discovery and Development